UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine

Journal of cardiovascular pharmacology, 1990-09, Vol.16 (3), p.501-505

1990

Volltextzugriff (PDF)

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

European journal of pharmacology, 1998-05, Vol.349 (2), p.263-268

1998

Volltextzugriff (PDF)

Protein Kinase Inhibitors and Blood Pressure Control in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 1991-01, Vol.17 (1), p.91-100

1991

Volltextzugriff (PDF)

Differential Hemodynamic Responses to Selective Inhibitors of Cyclic Nucleotide Phosphodiesterases in Conscious Rats

Journal of cardiovascular pharmacology, 1992-06, Vol.19 (6), p.937-944

1992

Volltextzugriff (PDF)

Species-Dependent Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 58993 and WIN 62005

Journal of cardiovascular pharmacology, 1995-01, Vol.25 (1), p.14-21

1995

Volltextzugriff (PDF)

Hemodynamic and Renal Effects of the Protein Kinase Inhibitor Staurosporine in Conscious Rats

Journal of cardiovascular pharmacology, 1992-10, Vol.20 (4), p.525-532

1992

Volltextzugriff (PDF)

The Effects of Iodixanol and Iopamidol on Hemodynamic and Cardiac Electrophysiologic Parameters In Vitro and In Vivo

Investigative radiology, 1991-08, Vol.26 (8), p.715-721

1991

Volltextzugriff (PDF)

Pharmacologic and Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 63291 and WIN 62582

Journal of cardiovascular pharmacology, 1994-09, Vol.24 (3), p.401-410

1994

Volltextzugriff (PDF)

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats

European journal of pharmacology, 1993-11, Vol.249 (3), p.293-297

1993

Volltextzugriff (PDF)

N ω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast

European journal of pharmacology, 1991-07, Vol.200 (1), p.83-87

1991

Volltextzugriff (PDF)

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: A Novel Class III Antiarrhythmic Agents

Journal of medicinal chemistry, 1995-07, Vol.38 (14), p.2551-2556

1995

Volltextzugriff (PDF)

Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits

Thrombosis research, 1994-09, Vol.75 (6), p.663-666

1994

Volltextzugriff (PDF)

Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats

European journal of pharmacology, 1990-08, Vol.185 (1), p.91-97

1990

Volltextzugriff (PDF)

Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology

Brain research, 1986-02, Vol.365 (1), p.21-29

1986

Volltextzugriff (PDF)

Stereoselective antihypertensive effects of the calcium channel blocker RO 23-6152 in two models of renin-dependent hypertension

Drug development research, 1991, Vol.24 (1), p.119-126

1991

Volltextzugriff (PDF)

Evidence for cGMP phosphodiesterase (cGPDE) inhibition as a novel approach for vasodilation/natriuresis

Journal of molecular and cellular cardiology, 1991-04, Vol.23, p.S89-S89

1991

Volltextzugriff (PDF)

Site-dependent central effects of aldosterone in rats

Brain research, 1987-01, Vol.401 (1), p.122-131

1987

Volltextzugriff (PDF)

Regional cerebral glucose utilization during vasopressin-induced barrel rotations or bicuculline-induced seizures in rats

Pharmacology, 1988, Vol.36 (1), p.1-8

1988

Volltextzugriff (PDF)

Vasopressin release induced by water deprivation: effects of centrally administered saralasin

Neuroendocrinology, 1983-01, Vol.37 (6), p.401-405

1983

Volltextzugriff (PDF)

Central effects of aldosterone infused into the rat subcommissural organ region

Neuroscience research, 1984-10, Vol.1 (5), p.341-351

1984

Volltextzugriff (PDF)

Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo

European journal of pharmacology, 1996-10, Vol.313 (1), p.89-96

1996

Volltextzugriff (PDF)

Effects of nucleotide cyclase activators on the depressor response to selective low Km cyclic AMP phosphodiesterase inhibitors in rats

Drug development research, 1991, Vol.23 (2), p.171-180

1991

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

Protein Kinase Inhibitors and Blood Pressure Control in Spontaneously Hypertensive Rats

Differential Hemodynamic Responses to Selective Inhibitors of Cyclic Nucleotide Phosphodiesterases in Conscious Rats

Species-Dependent Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 58993 and WIN 62005

Hemodynamic and Renal Effects of the Protein Kinase Inhibitor Staurosporine in Conscious Rats

The Effects of Iodixanol and Iopamidol on Hemodynamic and Cardiac Electrophysiologic Parameters In Vitro and In Vivo

Pharmacologic and Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 63291 and WIN 62582

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats

N ω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: A Novel Class III Antiarrhythmic Agents

Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits

Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats

Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology

Stereoselective antihypertensive effects of the calcium channel blocker RO 23-6152 in two models of renin-dependent hypertension

Evidence for cGMP phosphodiesterase (cGPDE) inhibition as a novel approach for vasodilation/natriuresis

Site-dependent central effects of aldosterone in rats

Regional cerebral glucose utilization during vasopressin-induced barrel rotations or bicuculline-induced seizures in rats

Vasopressin release induced by water deprivation: effects of centrally administered saralasin

Central effects of aldosterone infused into the rat subcommissural organ region

Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo

Effects of nucleotide cyclase activators on the depressor response to selective low Km cyclic AMP phosphodiesterase inhibitors in rats

Suchergebnisse filtern